olprinone has been researched along with Body Weight in 2 studies
olprinone: RN refers to HCl; structure given in first source
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Olprinone was infused at a rate of 0." | 1.39 | Population pharmacokinetics of olprinone in patients undergoing cardiac surgery with cardiopulmonary bypass. ( Fukumoto, K; Ishizuka, S; Tsubokawa, T; Ueno, K; Yamamoto, K, 2013) |
| "Treatment with olprinone attenuated the peritoneal exudation and the migration of polymorphonuclear cells caused by zymosan." | 1.37 | Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice. ( Bramanti, P; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Mazzon, E, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazzon, E | 1 |
| Esposito, E | 1 |
| Di Paola, R | 1 |
| Impellizzeri, D | 1 |
| Bramanti, P | 1 |
| Cuzzocrea, S | 1 |
| Tsubokawa, T | 1 |
| Ishizuka, S | 1 |
| Fukumoto, K | 1 |
| Ueno, K | 1 |
| Yamamoto, K | 1 |
2 other studies available for olprinone and Body Weight
| Article | Year |
|---|---|
Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Amylases; Animals; Apoptosis; Ascitic Fluid; Aspartate A | 2011 |
Population pharmacokinetics of olprinone in patients undergoing cardiac surgery with cardiopulmonary bypass.
Topics: Adult; Aged; Body Weight; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; C | 2013 |